Dr. Matko Kalac is a board-certified UCI Health hematologist-oncologist who specializes in the diagnosis and treatment of lymphomas. His clinical interests include non-Hodgkin and T cell lymphomas.
He earned his medical degree at the University of Zagreb School of Medicine in Croatia. He completed an internal medicine residency New York University's Grossman School of Medicine and NYU Langone Medical Center in New York City. Next he completed fellowship training in hematology and oncology at New York-Presbyterian/Columbia University Irving Medical Center, also in New York City.
A physician-scientist, Kalac's research interests include developing new treatment options for patients with non-Hodgkin and T cell lymphomas. He has served as a principal investigator on numerous clinical trials and he is the author or co-author of more than a dozen publications in major journals. A 2015 recipient of the American Society of Clinical Oncology's prestigious Young Investigator Award, he also received the National Center for Advancing Translational Sciences' TL1 Clinical Research Training Award.
Kalac, who also speaks Spanish, sees patients at the Chao Family Comprehensive Cancer Center in Orange.